New research compared the quality of sleep between women with POI and women of the same age with still functioning ovaries.
©Kittiphan - stock.adobe.com
Sleep disturbances are among the most common complaints of menopausal and postmenopausal women. A recent study appearing in Menopause compared the quality of sleep and fatigue between women with premature ovarian insufficiency (POI) receiving hormone therapy (HT) and women of the same age with still functioning ovaries.
The cross-sectional quantitative study included 162 participants aged 18 to 45 (61 diagnosed with POI and treated with HT; 61 with preserved ovarian function [control group]). A personal interview was used to collect demographic data.
The Pittsburgh Sleep Quality Index (PQSI), a 19-question self-evaluation of sleep over 1 month, was administered to the participants. The answers to the individual questions generated seven component scores ranging from 0 (no difficulty) to 3 (great difficulty). The sum of scores for the seven components yielded one global score ranging from 0 to 21 points, with higher scores indicating worse sleep quality (a score of 5 points or more corresponds to poor sleep quality.
The Chalder Fatigue Scale was also used to gather information on physical symptoms.
Mean ages of women with POI receiving HT and those in the control group were 35.03 ± 7.68 and 34.49 ± 7.55 years, respectively. Women with POI had been diagnosed 10.49 ± 7.44 years prior and had been receiving HT treatment for 7.84 ± 6.03 years. Women in the control group had a slightly higher mean number of children compared to the POI group (1.28 ± 1.38 children vs 0.44 ± 0.92 children, respectively).
Scores from the PQSI were slightly lower in the POI group than in the control group (7.69 ± 4.18 vs 8.03 ± 4.53), though there was no statistical difference between the groups. In the POI group, 69% were considered poor sleepers and 62% were identified as such in the control group.
While the overall scores did not vary greatly, the two groups did differ in the evaluated components. Women with POI had worse scores for questions related to sleep latency and use of sleep medication. Women in the control group rated themselves as having worse subjective sleep quality, more sleep disturbances, and more daytime dysfunction.
According to Chalder scale scores, women with POI had higher fatigue indices than those with preserved ovarian function (5.25 ± 2.78 vs 3.49 ± 1.78 points; P< 0.001). Fatigue was present in 59% of women in the POI group and 18% of those in the control group.
Although women with POI who receive HT have poor sleep quality, it is similar to women of the same age with preserved ovarian function. The authors believe this finding indicates the importance of discussing and evaluating sleep quality in all women who are nearing menopause or postmenopausal.
Impact of antiepileptic medications and sex hormones on maternal and child outcomes in epilepsy
May 16th 2024Paula Emanuela Voinescu, MD, PhD, director of the Women's Epilepsy Program at Brigham and Women's Hospital, talked about the influence of sex hormones on maternal outcomes in pregnant women with epilepsy treated with antiseizure medication.
Read More
PCOS and irregular cycles tied to cardiometabolic risks
May 15th 2024A comprehensive analysis reveals strong associations between polycystic ovary syndrome, irregular menstrual cycles, and increased risks of cardiometabolic conditions, underscoring the importance of proactive screening and intervention strategies.
Read More
Impact of primary care physicians on cervical cancer screening disparities
May 14th 2024A study highlights how having a primary care physician significantly increases the likelihood of cervical cancer screening among lesbian, gay, and bisexual cisgender women, addressing disparities exacerbated by systemic discrimination and healthcare access challenges.
Read More
Unlocking HPV prevention: Insights from 2022 data on vaccination trends
May 14th 2024Explore the latest findings revealing vaccination rates among children aged 9 to 17 years, uncovering demographic disparities and highlighting the crucial role of vaccination in combating human papillomavirus infections and related health risks.
Read More